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Abstract Hemodynamic abnormalities have been docu-
mented in the chronic fatigue syndrome (CFS), indicating
functional disturbances of the autonomic nervous system
responsible for cardiovascular regulation. The aim of this
study was to explore blood pressure variability and closed-
loop baroreﬂex function at rest and during mild orthostatic
stress in adolescents with CFS. We included a consecutive
sample of 14 adolescents 12–18 years old with CFS diag-
nosed according to a thorough and standardized set of
investigations and 56 healthy control subjects of equal sex
and age distribution. Heart rate and blood pressure were
recordedcontinuouslyandnon-invasivelyduringsupinerest
and during lower body negative pressure (LBNP) of
–20 mmHg to simulate mild orthostatic stress. Indices of
blood pressure variability and baroreﬂex function (a-gain)
were computed from monovariate and bivariate spectra in
the low-frequency (LF) band (0.04–0.15 Hz) and the high–
frequency (HF) band (0.15–0.50 Hz), using an autoregres-
sive algorithm. Variability of systolic blood pressure in the
HF range was lower among CFS patients as compared to
controls both at rest and during LBNP. During LBNP,
comparedtocontrols,a-gainHFdecreasedmore,anda-gain
LF and the ratio of a-gain LF/a-gain HF increased more in
CFS patients, all suggesting greater shift from parasympa-
thetic to sympathetic baroreﬂex control. CFS in adolescents
is characterized by reduced systolic blood pressure vari-
ability and a sympathetic predominance of baroreﬂex heart
rate control during orthostatic stress. These ﬁndings may
have implications for the pathophysiology of CFS in
adolescents.
Keywords Blood pressure variability   Baroreﬂex
sensitivity   Chronic fatigue syndrome   Autonomic
nervous system   Cardiovascular regulation
Introduction
The chronic fatigue syndrome (CFS) is a disabling disease,
mainly affecting adolescents and young adults (Natelson
2001); recently, the prevalence among 8–17 years olds was
reported as high as 1.3% (Farmer et al. 2004). Certain
infections (such as mononucleosis) and dramatic life events
are considered important precipitating factors (Natelson
2001). The condition usually last for years, but spontaneous
improvement is common, particularly among adolescents.
The CFS pathophysiology is unknown, but recent
evidence suggests that abnormalities of cardiovascular reg-
ulation may play an important role. Various forms of
orthostaticintolerancehave been demonstrated bothinadult
(Bou-Holaigah et al. 1995) and pediatric (Galland et al.
2008; Rowe et al. 1995; Rowe and Calkins 1998; Wyller
et al. 2007a, 2008b) patients, as well as abnormalities in
cerebral (Tanaka et al. 2002), muscle (McCully et al. 2004)
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namics.Takentogether,theseobservationsindicatethatCFS
is characterized by functional disturbances of the autonomic
nervous system affecting cardiovascular regulation.
One direction of investigation has applied variability
analyses of heart rate and blood pressure during orthostatic
challenge to explore in more detail the mechanisms of
autonomic cardiovascular control in CFS. However, CFS
studies based on such methodology have yielded conﬂict-
ing results (Boneva et al. 2007; Duprez et al. 1998; Stewart
2000; Yataco et al. 1997; Yoshiuchi et al. 2004). Two
reasons may account for this. First, most studies use an
ordinary head-up tilt-test for the orthostatic challenge.
However, in an experimental setting, the test may not be
ideal due to the varying effects of the muscle venous pump
among different participants in some experimental proto-
cols and the high rate of false positives in adolescents (De
Jong-De Vos van Steenwijk et al. 1995). Second, the
mathematical algorithm used for variability analyses may
not be optimal. For instance, when estimating baroreﬂex
sensitivity, most techniques fail to account for the feed-
forward effect (i.e. the mechanical inﬂuence) of heart rate
on blood pressure (Barbieri et al. 1996).
The technique of lower body negative pressure (LBNP)
is generally considered to mimic orthostasis effectively.
Compared to most upright tilt protocols, it provides a more
accurate tool for studies of cardiovascular adjustments
during orthostatic stress because the subjects do not move,
and the effect of the muscle venous pump is eliminated
(Stevens and Lamb 1965). Previously, we have reported
evidence of altered heart rate variability in CFS patients
during LBNP, indicating a predominance of sympathetic
heart rate control during mild orthostatic stress (Wyller
et al. 2008a). However, the autonomic neurons controlling
heart rate are continuously inﬂuenced by different sources,
including baroreceptor afferents, respiration and central
command (Saul 1990). Thus, the aim of the present study
was to assess blood pressure variability and one of the
factors that inﬂuence both RR and blood pressure vari-
ability, the arterial baroreﬂex, both at rest and during
LBNP. We hypothesized that indices of blood pressure
variability and baroreﬂex function would differ between
CFS patients and controls, indicating a predominance of
sympathetic cardiovascular control in the former.
Methods
Subjects
CFS patients 12–18 years old were consecutively recruited
from the outpatient clinic at the Department of Pediatrics,
Rikshospitalet University Hospital, Oslo, Norway, serving
as a national referral center for children and adolescents
with unexplained chronic fatigue. Based upon our previous
experiences, we assumed that a total number of approxi-
mately 15 CFS patient would be sufﬁcient (Wyller et al.
2008a, b) Other disease states that might explain their
present symptoms, such as autoimmune, endocrine, neu-
rologic or psychiatric disorders, were ruled out by a thor-
ough and standardized set of investigations. Different case
deﬁnitions of CFS exist. This study used a slight modiﬁ-
cation of the deﬁnition from the Centers for Disease
Control and Prevention (CDC). The main criterion of at
least 6 months of chronic or relapsing fatigue, severely
affecting daily activities (Fukuda et al. 1994), was required
in this study. However, the CDC deﬁnition also requires
patients having at least four of eight speciﬁc accompanying
symptoms. Since the validity of this last demand has been
questioned (Cho et al. 2006), particularly in the pediatric
population (Franklin 1998), accompanying symptoms were
not required in this study.
Healthy controls of 12–18 years old volunteered from
local schools. In line with our previous experimental
studies (Wyller et al. 2008a, b), we sought a 1:4 relation
between patients and controls in order to increase the sta-
tistical power. Through communication with the responsi-
ble teachers, a recruiting process was established that
assured an equal distribution of age and sex among the two
groups. Subjects having a chronic disease (such as allergy)
or using any medications on a regular basis (including
contraceptive pills) were excluded.
One week prior to the experiments, all participants were
instructed not to drink beverages containing alcohol or
caffeine, not to take any drugs and not to use tobacco
products. They were instructed to fast overnight the day
prior to the experiments.
Written, informed consent was obtained from all par-
ticipants and their parents. The study was approved by the
Regional committee for ethics in medical research. The RR
variability data from these same subjects were reported
previously (Wyller et al. 2008a).
Lower body negative pressure (LBNP) with handgrip
Experiments started at 11 a.m. The participants had been
offered a light, standardized meal (1–2 pieces of bread,
1 glass of juice) 2 h before, but were otherwise not allowed
to eat or drink. They lay supine with their lower body in a
plastic chamber, in which air could be evacuated very
rapidly, thus reaching a pre-deﬁned negative pressure
within milliseconds (Hisdal et al. 2003). In order to prevent
air leak, rubber devices were used to make a tight seal
around the subjects’ waist. They were lightly dressed; the
ambient temperature was kept between 23 and 26C, and
time of approximately 30 min was used for acclimatization
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123prior to experiments. They were familiarized with the test
situations in two pilot experiments.
Time of 5 min was used for baseline registration of
cardiovascular variables. Then LBNP of –20 mmHg was
applied. After 6 min of LBNP, the subjects were asked to
perform left-sided handgrip for 1 min with 30% of maxi-
mal voluntary contraction force. This procedure was
repeated once after a 1-min resting interval. One minute
after termination of the second handgrip, LBNP was turned
off. The cardiovascular adjustments during combined
LBNP and handgrip have been reported elsewhere (Wyller
et al. 2008b).
The procedure was performed twice with a 5-min rest
period between applications of LBNP. However, in two
subjects (one patient and one control), only one complete
run of LBNP and handgrip was performed due to dizziness
or other unpleasant experience. Two additional recordings
were excluded from the analyses due to low technical
quality.
Instantaneous heart rate (HR) was obtained from the R–R
interval (RRI) of the ECG. Photoplethysmography on the
right middle ﬁnger was used to obtain a non-invasive, con-
tinuous recording of arterial blood pressure (2300 Finapres,
Ohmeda, Madison, WI, USA). This method correlates sat-
isfactorilywithinvasivepressuremeasurements(Paratietal.
1989) and has also been validated in adolescents and chil-
dren (Seifer and Kenny 2001). In addition, non-invasive
techniques were used for continuous recording of aortic
blood ﬂow (bidirectional ultrasound Doppler velocimeter
located at the suprasternal notch), brachial artery blood ﬂow
(bidirectional ultrasound Doppler velocimeter located at the
elbow) and acral skin blood ﬂow (laser-Doppler probe
located at the right index ﬁnger). These measurements are
notreportedinthispaper.Allrecordedsignals,includingthe
pressure in the LBNP chamber, were on-line transferred to a
recording computer running a program for real-time data
acquisition (developed by Morten Eriksen, Department of
Physiology, University of Oslo, Norway).
RRI and BP monovariate spectral analysis
Beat-to-beat series of RRI and maximum (systolic: SBP) and
minimum (diastolic: DBP) interbeat arterial blood pressure
(ABP) values were converted to 3-Hz time series. For each
experimental run, segments of 120 s length were selected,
respectively, prior to LBNP and during LBNP prior to the
handgrip periods, and subjected to spectral analyses using an
autoregressive algorithm (Barbieri et al. 2001). Spectral
components were decomposed, and power densities were
computed in the low-frequency band (0.04–0.15 Hz) and the
high-frequency band (0.15–0.5 Hz). For subjects with two
experimental recordings, the arithmetical mean for each var-
iablewascomputedfromcorrespondingexperimentalepochs.
Spectral closed-loop analysis
The 3-Hz time series was also analyzed by a bivariate AR
Yule-Walker algorithm (Barbieri et al. 2001), where the
bivariate autoregressive model of order p is described by
the following vector equation:
Yn ½  ¼
X p
k¼1
Ak ½  Yn  k ½  þ Wn ½  :
When applied to the interactions between SBP (or DBP)
and RRI, the matrices are deﬁned as:
A k ½ ¼
a11 k ½  a12 k ½ 
a21 k ½  a22 k ½ 
  
; Y n ½  ¼
RRI½n 
ABP½n 
  
;
W n ½  ¼
wRRI½n 
wABP½n 
  
:
The p matrices of coefﬁcients A(k) were calculated by
solving the extended Yule-Walker equations. The order
p of the model was ﬁxed at 16 throughout the analysis. This
was done in order to guarantee a homogeneous, high-order
across-all segment. Of note, this order was generally higher
than the minimum order required by the Akaike criterion.
The bivariate coefﬁcients were used to simultaneously
analyze the gains and phases for the following transfer
functions:
GABP!RR f ðÞ ¼
A12 f ðÞ
1   A11 f ðÞ
;
the heart rate baroreﬂex feedback (SBP ? RRI and
DBP ? RRI, or alpha), and
GRR!ABP f ðÞ ¼
A21 f ðÞ
1   A22 f ðÞ
;
the feedforward from RRI to ABP (RRI ? SBP and
RRI ? DBP, or beta), where
Aij f ðÞ ¼
X p
k¼1
aij k ½  e j2pfk:
The feedback SBP ? RRI gain was taken as a measure
of the sensitivity of closed-loop baroreﬂex modulation of
RRI, while the feedforward RRI ? DBP gain was taken as
the measure of the sensitivity of the closed-loop
mechanical coupling between RRI and DBP ﬂuctuations.
Phase relationships were also assessed to investigate the
delays in the SBP–RRI and RRI–DBP interactions.
Gain and phase values were extracted in the low-fre-
quency (LF) band (0.04–0.15 Hz) and the high-frequency
(HF) band (0.15–0.5 Hz), anywhere the coherence between
RRI and SBP signals reached its maximum inside each
frequency band (Fig. 1). As previously suggested, the
a-gain for baroreﬂex feedback was characterized between
SBP and RR, and the b-gain feedforward was characterized
Eur J Appl Physiol (2011) 111:497–507 499
123Fig. 1 Individual univariate and bivariate spectra from one healthy
control (upper panels) and one CFS patient (lower panels) at baseline
(left) and during LBNP (right). Dark shadowed areas indicate the
low-frequency range (0.04–0.15 Hz); light shadowed areas indicate
the high-frequency range (0.1–0.50 Hz). Vertical dotted lines mark
the point of maximal coherence within each frequency band. Of note,
in the healthy control, LBNP results in a reduction of a-gain in both
frequency bands, whereas in the CFS patient, LBNP is associated with
a decrease of HF a-gain and an increase in LF a-gain
500 Eur J Appl Physiol (2011) 111:497–507
123between RR and DBP because of the direct effects of
changes in the RR interval on DBP (Barbieri et al. 2001).
For subjects with two experimental recordings, the arith-
metical mean for each variable was computed from cor-
responding experimental epochs.
Statistical analyses
Statistical analyses were carried out using SPSS statistical
software. Based upon inspection of plots, most variables
were appraised not to follow a normal distribution. Thus,
results are expressed as median with non-parametric 95%
conﬁdence intervals. The non-parametric Wilcoxon–Mann–
Whitney’s test (two-sided) was used to explore the differ-
ences between the two groups. Since the research questions
did not concern within group differences, statistical tests for
repeatedmeasurementswerenotapplied.ApvalueofB0.05
was considered statistically signiﬁcant. In order to reduce
the methodological problem of multiple comparisons, sta-
tistical tests were only performed for the cardiovascular
variables considered to be most relevant to our hypothesis.
Results
A total of 14 CFS patients and 56 healthy controls were
included in the study (Table 1). The two groups were
comparable regarding sex, age, weight and height. All were
of Caucasian ethnicity, except one control.
Mean duration of fatigue among the patients was
31 months. Their functional impairments were severe.
They were physically inactive, did not participate in leisure
activities and had a high level of school absenteeism.
However, no one was permanently bedridden. HR and DBP
were increased, and RRI was decreased both at rest and
during LBNP compared to controls (Table 2).
Results from the univariate spectral analyses of blood
pressure signals are shown in Tables 3 and 4 and Fig. 1.
For SBP, HFabs at baseline was signiﬁcantly lower among
CFS patients than controls. These differences persisted
during LBNP. DBP variability indices did not differ among
the two groups.
Results from bivariate spectral analyses are shown in
Tables 5 and 6 and Fig. 1. At rest, the a-phase HF for the
SBP–RR spectrum was more negative among CFS patients
than controls. Otherwise, no signiﬁcant differences were
identiﬁed among the two groups at rest. However, during
LBNP, a-gain HF tended to decrease more, and a-gain LF
tended to increase more among CFS patients than controls,
leading to a marked increase in the ratio of a-gain LF/
a-gain HF in the CFS-patients which was not present in the
controls. Also during LBNP, a-phase LF was less negative
in CFS patients than in controls. For feedforward b-gain,
no signiﬁcant differences were seen between CFS patients
and controls for any of the parameters measured. For all
computed bivariate spectra, median coherence values were
acceptable in the range of 0.66–0.83.
Discussion
The most important ﬁnding of this study is that the ratio of
LF:HF gain for baroreﬂex feedback increases markedly in
CFS patients in response to orthostatic stress, compared to
virtually no change in normal controls. The signiﬁcant
increase in the gain ratio was due to a combination of
increased LF gain and decreased HF gain in the CFS group,
while the controls only had a reduction in HF gain. These
ﬁndings indicate that mild orthostatic stress leads to a small
reduction of parasympathetically mediated heart rate con-
trol in both CFS patients and controls (decreased HF gain),
Table 1 Subject characteristics
Control (n = 56)
Mean (range)
CFS (n = 14)
Mean (range)
Number of patients 56 14
Female gender, n (%) 33 (58.9) 9 (64.3)
Age (years) 15.6 (13–18) 15.2 (12–18)
Weight (kg) 61.6 (44–99) 59.5 (43–92)
Height (cm) 171.5 (149–195) 172.2 (160–192)
Body surface area (m
2) 1.7 (1.4–2.2) 1.7 (1.4–2.2)
Duration of fatigue (months) 31.3 (6–60)
Table 2 Standard hemodynamic variables at baseline and during LBNP -20 mmHg: median (conﬁdence interval)
Baseline LBNP
Control (n = 56) CFS (n = 14) Control (n = 56) CFS (n = 14)
Heart rate (beats/min) 65.1 (62.0–67.6) 71.9 (66.1–81.5) 70.8 (67.6–75.7) 86.2 (80.6–93.0)
RR-interval (ms) 921 (887–968) 834 (736–908) 847 (793–887) 696 (645–744)
Systolic blood pressure (mmHg) 118.6 (113.5–123.9) 115.6 (110.5–130.3) 117.4 (112.9–122.1) 118.2 (110.7–133.1)
Diastolic blood pressure (mmHg) 63.8 (62.1–66.0) 69.4 (65.5–74.9) 66.3 (64.1–67.9) 73.8 (68.7–79.5)
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123but a signiﬁcant increase in sympathetically mediated
baroreﬂex gain in CFS patients (increased LF gain) which
is not observed in controls.
In addition, reduced HF SBP variability was observed in
CFS patients compared to controls, possibly reﬂecting a
reduced effect of respiration on RR or SBP in CFS patients.
Blood pressure variability in CFS
The mechanical effect of ventilation is a signiﬁcant source
of blood pressure variability in the HF range (Malpas 2002;
Zhang et al. 2002). Thus, our ﬁndings of reduced HF
variability of SBP, which has not been previously reported,
suggest either an altered ventilatory pattern or an altered
effect of respiratory activity on SBP among CFS patients.
There are several reports of reduced heart rate variability in
the HF range, both at rest (Stewart 2000) and during
orthostatic challenge in CFS patients (Stewart 2000;
Wyller et al. 2007c, 2008a). Since respiratory activity is
also the primary source of heart rate variability in the HF
range (Saul 1990), the reduced HF variability of SBP
observed here could be due to a reduced effect of respi-
ration on heart rate (respiratory sinus arrhythmia). How-
ever, since respiratory patterns were not controlled and a
quantitative respiratory signal was not measured in these
studies, the precise origin of reduced SBP variability in the
HF range cannot be determined. Future research could
focus on possible alterations in CFS ventilatory patterns
and the relationships between ventilation and both heart
rate and blood pressure in these patients.
No differences between CFS patients and controls were
observedforbloodpressurevariabilityintheLFrangeeither
at rest or during LBNP. An important source of such vari-
ability is sympathetically controlled vasomotion (Malpas
2002), which consequently appears to be unaltered in CFS.
Although these ﬁndings are consistent with previously
reported data from our laboratory (Wyller et al. 2007c),
they contrast with Stewart’s (2000) study of adolescent
CFS patients, where increased blood pressure variability
was noted in the LF range during 70 head-up tilt. This
apparent inconsistency could be entirely explained by dif-
ferent experimental protocols: First, LBNP and upright tilt,
although similar in terms of physiological stress, do not
result in identical hemodynamic responses. Second, LBNP
of -20 mmHg used in this study, corresponding to head-up
tilt of 20–30, represents a much milder orthostatic chal-
lenge than 70 head-up tilt and might have been insufﬁcient
to provoke a difference between the two groups.
Dynamic closed-loop baroreﬂex assessment in CFS
The baroreﬂex feedback mechanism includes both
sympathetic and parasympathetic neural connections
emanatingfromthe brainstem cardiovascularcontrol center
to the sinus node (Lanfranchi and Somers 2002; Saul 1990).
Because sympathetic heart rate control is relatively slow it
onlycontrolsheartratechangesintheLFrange,whereasthe
parasympathetic system has broad-band characteristics,
operating in the LF as well as the HF range.Previous studies
applying the same bivariate technique used here have
demonstrated that during upright posture the a-gain
decreases in both LF and HF ranges (Barbieri et al. 2002),
presumablysecondary toparasympathetic withdrawal.With
the milder orthostatic stress in this study, we observed a
similar decrease for both controls and CFS patients but only
in the HF range. Among CFS patients, a-gain LF actually
increased during LBNP. The net result was a marked and
signiﬁcant increase in the ratio a-gain LF/a-gain HF,
strongly suggesting that in addition to the reduced para-
sympathetic heart rate control, there was enhanced sympa-
thetic heart rate control mediated by the baroreﬂex.
The observed increase in the sympathetic component of
the baroreceptor feedback with even mild orthostatic stress
in CFS patients indicates early sympathetic activation and
may reﬂect diminished baroreﬂex reserve for more severe
stressors. These changes further suggest that the baroreﬂex
may have a diminished ability to buffer a variety of internal
and external inﬂuences on arterial pressure, but particularly
those related to upright activity and ambulation, in line
with our previous report on the combined effect of ortho-
static stress and isometric exercise in CFS patients (Wyller
et al. 2008b).
The function of the baroreceptor reﬂex has been addres-
sed in two previous CFS studies. In a group of adolescent
CFS patients and controls, Stewart (2000) reported signiﬁ-
cantly lower a-gain in the HF as well as the LF range among
CFSpatients,both during restand during 70head-up tilt.In
adult CFS patients, Peckerman et al. (2003) reported
enhanced decline in baroreceptor sensitivity upon standing
as compared to controls. However, the sequential method
adoptedinthelatterstudydoesnotallowseparateestimation
of LF and HF gain, making it most sensitive for parasym-
pathetic heart rate control. Differences from the current
study might be explained by different inclusion criteria,
experimentalprotocolsandmathematicalalgorithms.Taken
together, however, like this study, they indicate a sympa-
thetic predominance of baroreﬂex heart rate control during
orthostatic stress in CFS patients.
Cardiovascular dysregulation in CFS
In agreement with past reports, the ﬁndings from this study
conﬁrm that CFS patients have functional disturbances of
the autonomic nervous system affecting cardiovascular
regulation. The underlying mechanism for this disturbance
has been disputed.
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absolute or relative hypovolemia, which has indeed been
reported previously (Farquhar et al. 2002; Streeten 2001;
Streeten et al. 2000; Hurwitz et al. 2009). However,
detailed studies of baroreﬂex function with techniques
similar to ours have revealed a reduced LF baroreﬂex gain
at rest following blood donation (Triedman et al. 1993) and
furosemide treatment (Iwasaki et al. 2000) and a further
attenuation of LF baroreﬂex gain in hypovolemic individ-
uals during orthostatic stress (Triedman et al. 1993).
Moreover, an attenuation of LF baroreﬂex gain has been
demonstrated during experimentally induced hypovolemia
by LBNP (Barbieri et al. 2002). Contrasting these results,
we found equal LF baroreﬂex gain among controls and
CFS patients at rest and increased LF baroreﬂex gain in
CFS patients during orthostatic stress, making hypovol-
emia an unlikely explanation.
A second possibility would be cardiovascular decondi-
tioning due to physical inactivity in CFS patients (De
Lorenzo et al. 1998). The deconditioning inﬂuence on
cardiovascular control appears to be partly a consequence
of concomitant hypovolemia (Iwasaki et al. 2000), adding
to the relevance of the reasoning above. Furthermore, in
adults, both sedentary and gravitational deconditionings
seem to be associated with attenuated sympathetic
responsiveness during orthostatic stress (Levine et al. 1991;
Sun et al. 2003), and endurance training in sedentary
individuals tends to increase LF baroreﬂex gain at rest
(Iwasaki et al. 2003). In a previous study of healthy ado-
lescents, the degree of aerobic ﬁtness did not predict car-
diac autonomic responses during head-up tilt (Brunetto
et al. 2005). Finally, no one of the CFS patients in this
study was permanently bedridden, and previous evidence
suggests that intermittent exposure to gravity during
a bed-rest period is sufﬁcient to prevent gravitational
deconditioning (Sun et al. 2003; Zhang et al. 2000). Taken
together, cardiovascular deconditioning does not seem to
explain the results reported in this study.
A third possible explanation is a discrete disturbance of
CNS autonomic control, such as temporary central reset-
ting, redeﬁning the homeostatic range of the baroreﬂex
(Goldstein 2001). The smaller negative value for a-phase
LF among CFS patients as compared to controls during
LBNP suggests a shortened response time within the
sympathetic part of the baroreﬂex, possibly caused by
central enhancement of neural transmission. Furthermore,
as orthostatic challenge neither altered feedforward b-gain
nor DBP variability in the LF range differently among CFS
patients, the sympathetic predominance does not seem to
be a reﬂection of blood pressure buffering, further pointing
towards a central mechanism. Central resetting is not a
common feature of orthostatic challenge, but does occur
during aerobic exercise, resulting in attenuation of
parasympathetic and predominance of sympathetic heart
rate control (Macor et al. 1996; Spadacini et al. 2006),
analogous to what we report in this study.
Data quality and study limitations
The responses among healthy adolescents to LBNP were
similar in all respect to responses among healthy adults in
previously reported LBNP experiments from our institu-
tions, supporting the validity of this study (Barbieri et al.
2002). Furthermore, coherence values were well above 0.5
for all computed bivariate spectra, supporting the validity
of the calculated gain and phase values.
Blood and/or plasma volume were not measured, leav-
ing the question of hypovolemia unresolved. Finally,
respiratory activity has been shown to change during
orthostatic challenge and could therefore inﬂuence car-
diovascular variability (Cooke et al. 1999); however, ven-
tilation was not controlled for in this study.
Concluding remarks
Our ﬁndings of cardiovascular dysregulation point towards a
discrete disturbance of CNS autonomic control in CFS
patients. This may represent a distinct pathophysiologic
phenomenon possibly conceptualized as a mismatch phe-
nomenon, in which sensory input during orthostatic chal-
lenge evokes a disproportional or ‘untuned’ autonomic
response. This concept is compliant with recently proposed
theories of CFS pathophysiology, such as the theory of
centralsensitization(Yunus2007)andourrecentlyproposed
theory of sustained arousal (Wyller et al. 2009). On a more
general level, such a concept is in line with recent models on
the mechanistic link between psychosocial stressors and
cardiovascular morbidity (Goldstein 2001; Lucini et al.
2008). Further research should aim at exploring these rela-
tions in more detail, both in CFS and other related disorders.
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